Downloading The Data

Venetoclax-Obinutuzumab Shows Ongoing Benefits in Chronic Lymphocytic Leukemia: Highlights From EHA 2023

ASCO® 2022 Highlights: Combination Therapy for Chronic Lymphocytic Leukemia

ESMO Congress 2021 Highlights: Emerging Treatments for Advanced Gastric or Gastroesophageal Junction Cancers

ASH Conference 2020 Highlights on Acute Myeloid Leukemia

ASH Conference 2020 Highlights on CAR-T Therapies for Relapsed/Refractory Multiple Myeloma